GIC Sub-Industry 'Pharmaceuticals': 98 results
| Symbol | Industry | Market Cap | Fund. Score | Div. Score | Tech. Score | P/E | Return 12m vs S&P 500 |
|---|---|---|---|---|---|---|---|
| LLY Eli Lilly |
Pharmaceuticals
Insulin, Diabetes, Oncology |
963B | 82.1% | 76.4% | 59.7% | 52.6 | 17.4% |
| JNJ Johnson & Johnson |
Pharmaceuticals
Pharmaceuticals, Devices, Lenses |
499B | 73.9% | 63.0% | 64.5% | 20.0 | 25.9% |
| ZEG AstraZeneca |
Pharmaceuticals
Oncology, Cardiovascular |
283B | 86.5% | 51.2% | 50.6% | 30.6 | 9.10% |
| AZN AstraZeneca |
Pharmaceuticals
Oncology, Cardiovascular |
283B | 79.5% | 46.6% | 59.9% | 30.3 | 21.8% |
| NVS Novartis |
Pharmaceuticals
Cardiovascular, Oncology |
265B | 91.8% | 61.4% | 74.4% | 18.9 | 23.6% |
| MRK Merck |
Pharmaceuticals
Oncology Vaccines Antimicrobials |
263B | 83.0% | 67.5% | 47.7% | 13.9 | -2.54% |
| NVO Novo Nordisk |
Pharmaceuticals
Insulin, Obesity, Growth, Blood |
226B | 89.4% | 45.6% | -36.3% | 13.9 | -41.9% |
| PFE Pfizer |
Pharmaceuticals
Medicines, Vaccines, Biosimilars |
142B | 57.6% | 78.2% | -5.56% | 14.5 | -14.7% |
| SNY Sanofi |
Pharmaceuticals
Vaccines, Immunology, Oncology |
117B | 61.7% | 59.9% | 5.34% | 15.8 | -13.7% |
| SAN Sanofi |
Pharmaceuticals
Vaccines, Oncology, Neurology |
116B | 75.2% | 69.7% | -28.5% | 15.7 | -23.6% |
| BMY Bristol-Myers |
Pharmaceuticals
Oncology, Immunotherapy |
109B | 73.4% | 80.7% | -0.17% | 18.0 | -12.7% |
| GSK GlaxoSmithKline |
Pharmaceuticals
Vaccines, Specialty Medicines |
99.2B | 76.9% | 24.0% | 80.4% | 13.7 | 31.1% |
| GS71 GSK |
Pharmaceuticals
Vaccines, Specialty Medicines |
98.5B | 80.1% | 34.7% | 56.2% | 13.7 | 16.9% |
| MRK Merck KGaA |
Pharmaceuticals
Reagents, Filtration, Antibodies |
62.2B | 61.9% | 65.6% | -14.9% | 18.0 | -23.1% |
| ZTS Zoetis |
Pharmaceuticals
Vaccines, Parasiticides |
55.7B | 83.4% | 74.0% | -51.8% | 21.8 | -34.2% |
| TAK Takeda |
Pharmaceuticals
Oncology, Gastroenterology |
52.0B | 62.5% | 36.8% | 57.0% | 223 | 9.29% |
| BAYN Bayer NA |
Pharmaceuticals
Pharmaceuticals, Consumer Health |
42.5B | 46.2% | 1.74% | 38.5% | - | 70.7% |
| TEVA Teva Pharma |
Pharmaceuticals
Generics, Respiratory, CNS |
35.8B | 53.1% | 17.4% | 70.2% | 51.2 | 27.8% |
| RPRX Royalty Pharma |
Pharmaceuticals
Royalties, Biopharma, Investments |
22.7B | 56.4% | 60.4% | 76.2% | 22.2 | 33.1% |
| VTRS Viatris |
Pharmaceuticals
Prescription, Generic, Biosimilar |
14.4B | 28.9% | 53.9% | 29.4% | - | -6.45% |
| RDY Dr. Reddy’s |
Pharmaceuticals
Generics, APIs, Biologics |
11.6B | 76.5% | 11.8% | -18.1% | 17.8 | -28.2% |
| ELAN Elanco Animal |
Pharmaceuticals
Parasiticides, Vaccines |
11.2B | 41.7% | - | 67.7% | 322 | 70.0% |
| IPN Ipsen |
Pharmaceuticals
Oncology, Rare Disease |
11.2B | 87.4% | 60.2% | 29.1% | 21.6 | -7.65% |
| JAZZ Jazz |
Pharmaceuticals
Sleep Disorder Treatments |
10.3B | 51.2% | - | 34.5% | - | 12.6% |
| AXSM Axsome Therapeutics |
Pharmaceuticals
Antidepressant, Anti-Sleepiness |
9.21B | 32.4% | - | 65.6% | - | 71.5% |
| TERN Terns |
Pharmaceuticals
Kinase Inhibitor, Thyroid Agonist |
4.39B | 34.6% | - | 57.7% | - | 509% |
| CORT Corcept |
Pharmaceuticals
Korlym, Relacorilant |
4.03B | 67.0% | - | -15.0% | 43.9 | -40.3% |
| AMRX Amneal |
Pharmaceuticals
Generics, Injectables |
3.96B | 60.9% | - | 75.4% | - | 38.4% |
| VIRP Virbac |
Pharmaceuticals
Vaccines, Antibiotics |
3.51B | 85.5% | 58.9% | 42.7% | 22.6 | -4.26% |
| TARS Tarsus |
Pharmaceuticals
Eye Therapy, Mite Blepharitis |
3.48B | 36.6% | - | 51.9% | - | 19.6% |
| PBH Prestige Brand |
Pharmaceuticals
Analgesic, Diaper, Throat, Eye |
3.01B | 63.6% | 1.0% | -34.4% | 15.2 | -27.3% |
| LQDA Liquidia |
Pharmaceuticals
Dry Powder Injectable Liposomal |
3.00B | 27.3% | - | 64.7% | - | 115% |
| WVE Wave Life Sciences |
Pharmaceuticals
RNA Editing, GalNAc-Conjugated |
2.96B | 35.9% | - | 9.44% | - | 0.25% |
| SUPN Supernus |
Pharmaceuticals
ADHD, Epilepsy, Parkinson |
2.85B | 45.9% | - | 69.7% | - | 13.6% |
| BHC Bausch Health |
Pharmaceuticals
Gastroenterology, Dermatology |
2.67B | 51.3% | 3.14% | 6.21% | 7.43 | -16.2% |
| OCUL Ocular Therapeutix |
Pharmaceuticals
Dexamethasone, Axitinib, Travoprost |
2.59B | 31.9% | - | 26.7% | - | 8.41% |
| HRMY Harmony |
Pharmaceuticals
Wakix, Pitolisant, BP1.15205 |
2.16B | 91.9% | - | 11.7% | 11.9 | -7.33% |
| DMP Dermapharm Holding |
Pharmaceuticals
Branded Generics, OTC |
2.12B | 73.3% | 29.6% | 9.15% | 16.9 | -16.1% |
| AVDL Avadel |
Pharmaceuticals
Sodium Oxybate, Narcolepsy |
2.11B | 64.0% | - | 56.6% | - | 69.8% |
| MAZE Maze Therapeutics |
Pharmaceuticals
MZE829, MZE782, MZE001, Renal |
1.99B | 24.7% | - | 83.9% | - | 111% |
| PRGO Perrigo |
Pharmaceuticals
OTC, Vitamins, Infant Formula |
1.91B | 46.5% | 76.5% | -57.8% | - | -47.6% |
| OGN Organon |
Pharmaceuticals
Contraception, Fertility |
1.88B | 56.7% | 11.8% | -47.3% | 3.79 | -56.0% |
| HROW Harrow Health |
Pharmaceuticals
Antibiotic, Steroid |
1.81B | 43.8% | - | 69.1% | - | 19.3% |
| ANIP ANI Pharmaceuticals |
Pharmaceuticals
Injectables, Softgels, Cortrophin |
1.76B | 68.7% | - | 51.7% | 49.0 | 26.4% |
| INVA Innoviva |
Pharmaceuticals
Inhaled Combo, Vasoconstrictor |
1.66B | 80.7% | 1.25% | 25.3% | 13.4 | -4.08% |
| TRVI Trevi Therapeutics |
Pharmaceuticals
Chronic Cough, Nalbuphine |
1.61B | 37.3% | - | 56.4% | - | 135% |
| PAHC Phibro Animal |
Pharmaceuticals
Antibacterials, Vaccines |
1.56B | 61.6% | 36.1% | 61.3% | 22.3 | 58.8% |
| EVT Evotec SE |
Pharmaceuticals
Oncology, Autoimmune, Metabolic |
1.48B | 22.2% | - | -49.1% | - | -35.8% |
| EYPT Eyepoint |
Pharmaceuticals
Sustained Drug Implant, VEGF |
1.45B | 29.0% | - | 74.1% | - | 58.4% |
| COLL Collegium |
Pharmaceuticals
Stimulant, Buccal, Opioid |
1.44B | 78.9% | - | 58.8% | 27.9 | 23.6% |
| RAPP Rapport |
Pharmaceuticals
Epilepsy, Neuropathic Pain |
1.34B | 31.5% | - | 61.4% | - | 43.3% |
| AMLX Amylyx |
Pharmaceuticals
Avexitide, AMX0035, AMX0114, GLP-1 |
1.25B | 30.2% | - | 21.7% | - | 165% |
| SEPN Septerna, Common |
Pharmaceuticals
GPCR, Oral, Small-Molecule |
1.25B | 46.7% | - | 41.7% | - | 4.32% |
| AMPH Amphastar P |
Pharmaceuticals
Injectable, Inhalation |
1.25B | 76.4% | - | -6.15% | 11.9 | -36.0% |
| XERS Xeris |
Pharmaceuticals
Glucagon, Cortisol, Paralysis |
1.20B | 63.5% | - | 51.4% | - | 104% |
| PHAT Phathom |
Pharmaceuticals
Tablet, Antibiotic, Proton-Pump |
1.18B | 66.3% | - | 59.0% | - | 89.7% |
| OMER Omeros |
Pharmaceuticals
Narsoplimab, OMS1029, Zaltenibart |
1.16B | 42.0% | - | 33.8% | - | 14.9% |
| PCRX Pacira BioSciences |
Pharmaceuticals
EXPAREL, ZILRETTA, Iovera |
1.10B | 62.7% | - | 13.4% | 52.0 | 18.3% |
| TLRY Tilray |
Pharmaceuticals
Cannabis, Beverages, Wellness |
1.04B | 47.7% | - | -44.7% | - | -43.7% |
| CRON Cronos |
Pharmaceuticals
Dried Flower, Pre-Roll, Oil |
1.03B | 47.0% | - | 44.0% | 24.6 | 10.3% |
| TBPH Theravance |
Pharmaceuticals
COPD, Nebulizer, Norepinephrine |
948M | 51.0% | - | 84.3% | 32.8 | 77.6% |
| ELVN Enliven |
Pharmaceuticals
Kinase Inhibitor, HER2 Inhibitor |
922M | 32.4% | - | -1.37% | - | -18.7% |
| CRMD CorMedix |
Pharmaceuticals
Antimicrobial, Catheter, Solution |
880M | 92.2% | - | -19.8% | 5.05 | -41.3% |
| NKTR Nektar Therapeutics |
Pharmaceuticals
Autoimmune, Inflammation, Cancer |
874M | 32.5% | - | 48.9% | - | 105% |
| ARVN Arvinas |
Pharmaceuticals
Protac, Degrader, Breast |
842M | 39.9% | - | -0.81% | - | -48.1% |
| AQST Aquestive |
Pharmaceuticals
Buccal Film, Sublingual Film, Oral |
788M | 59.5% | - | 58.8% | - | 67.7% |
| NBY NovaBay |
Pharmaceuticals
Wound Cleanser, Hypochlorous Acid |
781M | 51.5% | 33.2% | 34.4% | 1.20 | 1,789% |
| FULC Fulcrum |
Pharmaceuticals
Pociredir, Losmapimod, Fetal |
746M | 23.1% | - | 24.7% | - | 90.7% |
| VTYX Ventyx Biosciences |
Pharmaceuticals
VTX958, Tamuzimod, VTX2735 |
717M | 35.3% | - | 63.3% | - | 420% |
| ANRO Alto Neuroscience |
Pharmaceuticals
Antidepressant, Cognitive |
514M | 44.2% | - | 32.6% | - | 204% |
| BIOA BioAge Labs |
Pharmaceuticals
Azelaprag, BGE-102, Obesity |
460M | 46.6% | - | 65.4% | 0.94 | 131% |
| ETON Eton |
Pharmaceuticals
Adrenal, Wilson, PKU, Tyrosinemia |
453M | 57.0% | - | 29.7% | - | 16.2% |
| SIGA SIGA Technologies |
Pharmaceuticals
Antiviral, Smallpox Treatment |
449M | 79.6% | 79.8% | 29.7% | 6.09 | 0.60% |
| CGC Canopy Growth |
Pharmaceuticals
Dried Flower, Extracts, Edibles |
438M | 17.5% | - | -32.5% | - | -59.0% |
| EOLS Evolus |
Pharmaceuticals
Botulinum Toxin, Hyaluronic Acid |
436M | 28.9% | - | -63.4% | - | -52.5% |
| SNDL SNDL |
Pharmaceuticals
Cannabis, Alcohol, Retail, Flower |
427M | 50.9% | - | -47.0% | - | -26.3% |
| CTNM Contineum |
Pharmaceuticals
PIPE-791, PIPE-307, CTX-343 |
416M | 30.5% | - | -35.8% | - | -42.0% |
| RLMD Relmada |
Pharmaceuticals
Gemcitabine, Docetaxel |
331M | 45.2% | - | 75.7% | - | 728% |
| ACRS Aclaris |
Pharmaceuticals
JAK Inhibitor, TSLP Antibody |
312M | 32.8% | - | -10.4% | - | -7.94% |
| AARD Aardvark |
Pharmaceuticals
ARD-101, ARD-201, Small-Molecule |
286M | 25.5% | - | 13.1% | - | -11.4% |
| NMRA Neumora |
Pharmaceuticals
Depression, Agitation, Alzheimer |
282M | 49.5% | - | -14.7% | - | -16.9% |
| AVIR Atea |
Pharmaceuticals
Antiviral, Oral, Hepatitis |
272M | 30.4% | - | 4.41% | - | -8.67% |
| ACB Aurora Cannabis |
Pharmaceuticals
Cannabis, Oils, Capsules, Edibles |
246M | 67.1% | - | -46.4% | - | -18.4% |
| ALTS ALT5 Sigma |
Pharmaceuticals
Trading Platform, Payment Gateway |
239M | 27.8% | 1.0% | -33.2% | - | -78.1% |
| MDWD Mediwound |
Pharmaceuticals
Burn Debridement, Chronic Wound |
237M | 20.2% | - | 28.1% | - | 1.86% |
| OGI OrganiGram Holdings |
Pharmaceuticals
Cannabis, Flower, Pre-Rolls |
226M | 20.8% | - | 4.26% | - | -10.9% |
| MIST Milestone |
Pharmaceuticals
Etripamil, Calcium Channel |
172M | 24.5% | - | 0.15% | - | -15.9% |
| SAVA Cassava Sciences |
Pharmaceuticals
Simufilam, SavaDx |
142M | 34.6% | 1.0% | -47.6% | - | -36.0% |
| IRD Opus Genetics |
Pharmaceuticals
Gene Therapy, Retinal Diseases |
139M | 40.0% | - | 27.2% | - | 16.6% |
| ELTX Elicio Therapeutics |
Pharmaceuticals
Vaccine, Lymph Node, Preclinical |
136M | 45.7% | - | 0.61% | - | 22.8% |
| CNTX Context |
Pharmaceuticals
Anti-Claudin6 Bispecific, T-Cell |
135M | 29.8% | - | 59.7% | - | 11.7% |
| VRCA Verrica |
Pharmaceuticals
Cantharidin, VP-102, VP-315 |
133M | 26.1% | - | 16.6% | - | -3.15% |
| SCLX Scilex Holding |
Pharmaceuticals
Lidocaine, Migraine, Anti-Gout |
92.1M | 67.5% | - | -47.2% | - | -29.2% |
| CPIX Cumberland |
Pharmaceuticals
Acetaminophen Poisoning Injection |
59.8M | 49.4% | - | 59.7% | - | 83.0% |
| EVOK Evoke Pharma |
Pharmaceuticals
Nasal Spray, Diabetic Gastroparesis |
19.0M | 30.9% | - | 48.9% | - | 330% |
| ASBP Aspire BioPharma |
Pharmaceuticals
Sublingual Tablets, Aspirin |
18.3M | 39.1% | - | -81.3% | - | -99.2% |
| KALA Kala |
Pharmaceuticals
KPI-012, KPI-014, Eye Therapy |
14.3M | 25.4% | - | -60.4% | - | -92.0% |
| YCBD cbdMD |
Pharmaceuticals
CBD Tinctures, Gummies, Topicals |
6.58M | 15.4% | - | -50.0% | 1.45 | -77.1% |